Trinity Biotech plc (ADR) (NASDAQ:TRIB)

CAPS Rating: 4 out of 5

The Company develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market.

Recs

0
Player Avatar foolfully (69.10) Submitted: 11/21/2012 4:24:44 PM : Outperform Start Price: $14.15 TRIB Score: +7.44

100

Featured Broker Partners


Advertisement